Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
February 15, 2012
Double blind, randomized controlled trials (DBRCTs) are generally perceived to be the gold standard for clinical trials. While DBRCTs clearly can produce high-quality data, it is important to question the quality of the trial design, trial conduct clinical data management, statistical analysis and interpretation.
You May Also Like